Next, we determined whether 14-3-3 σ promoter methylation was correlated with clinicopathological characteristics in breast cancer, including age status, tumor grade, clinical stage, lymph node status, histological subtype, ER status, PR status, and HER2 status (Figures 5 and 6). This evidence concerns the gene ESR1 and breast cancer.